{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T18:55:54Z","timestamp":1794855354919,"version":"4.9.1"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,8,7]],"date-time":"2023-08-07T00:00:00Z","timestamp":1691366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,8,7]],"date-time":"2023-08-07T00:00:00Z","timestamp":1691366400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004085","name":"Ministry of Education, Science and Technology","doi-asserted-by":"publisher","award":["NRF-2018R1A6A1A03025221"],"award-info":[{"award-number":["NRF-2018R1A6A1A03025221"]}],"id":[{"id":"10.13039\/501100004085","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Cancer-related fatigue (CRF) affects therapeutic compliance and clinical outcomes including recurrence and mortality. This study aimed to comprehensively and comparatively assess the severity-based prevalence of CRF. From two public databases (PubMed and Cochrane Library), we extracted data containing information on both prevalence and severity of fatigue in cancer patients through December 2021. We conducted a meta-analysis to produce point estimates using random effects models. Subgroup analyses were used to assess the prevalence and severity by the organ\/system tumor development, treatment phase, therapeutic type, sex and assessment method. A total of 151 data (57 studies, 34,310 participants, 11,805 males and 22,505 females) were selected, which indicated 43.0% (95% CI 39.2\u201347.2) of fatigue prevalence. The total CRF prevalence including \u2018mild\u2019 level of fatigue was 70.7% (95% CI 60.6\u201383.3 from 37 data). The prevalence of \u2018severe\u2019 fatigue significantly varied by organ\/system types of cancer origin (highest in brain tumors 39.7% vs. lowest in gynecologic tumors 3.9%) and treatment phase likely 15.9% (95% CI 8.1\u201331.3) before treatment, 33.8% (95% CI 27.7\u201341.2) ongoing treatment, and 24.1% (95% CI 18.6\u201331.2) after treatment. Chemotherapy (33.1%) induced approximately 1.5-fold higher prevalence for \u2018severe\u2019 CRF than surgery (22.0%) and radiotherapy (24.2%). The self-reported data for \u2018severe\u2019 CRF was 20-fold higher than those assessed by physicians (23.6% vs. 1.6%). Female patients exhibited a 1.4-fold higher prevalence of \u2018severe\u2019 fatigue compared to males. The present data showed quantitative feature of the prevalence and severity of CRF based on the cancer- or treatment-related factors, sex, and perspective of patient versus physician. In the context of the medical impact of CRF, our results provide a comparative reference to oncologists or health care providers making patient-specific decision.<\/jats:p>","DOI":"10.1038\/s41598-023-39046-0","type":"journal-article","created":{"date-parts":[[2023,8,7]],"date-time":"2023-08-07T11:01:56Z","timestamp":1691406116000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":136,"title":["Prevalence of cancer-related fatigue based on severity: a systematic review and meta-analysis"],"prefix":"10.1038","volume":"13","author":[{"given":"Ye-Eun","family":"Kang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji-Hae","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na-hyun","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yo-Chan","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun-Jung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang-Gue","family":"Son","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,7]]},"reference":[{"issue":"8","key":"39046_CR1","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.6004\/jnccn.2015.0122","volume":"13","author":"AM Berger","year":"2015","unstructured":"Berger, A. M. et al. Cancer-related fatigue, version 2.2015. J. Natl. Compr. Cancer Netw. 13(8), 1012\u20131039 (2015).","journal-title":"J. Natl. Compr. Cancer Netw."},{"issue":"5","key":"39046_CR2","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1177\/1049909110391464","volume":"28","author":"J Kirkova","year":"2011","unstructured":"Kirkova, J. et al. The relationship between symptom prevalence and severity and cancer primary site in 796 patients with advanced cancer. Am. J. Hosp. Palliat. Med.\u00ae 28(5), 350\u2013355 (2011).","journal-title":"Am. J. Hosp. Palliat. Med.\u00ae"},{"issue":"2","key":"39046_CR3","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1002\/cncr.10245","volume":"94","author":"D Cella","year":"2002","unstructured":"Cella, D., Js, L., Chang, C. H., Peterman, A. & Slavin, M. Fatigue in cancer patients compared with fatigue in the general United States population. Cancer 94(2), 528\u2013538 (2002).","journal-title":"Cancer"},{"issue":"9","key":"39046_CR4","doi-asserted-by":"publisher","first-page":"2759","DOI":"10.1158\/1078-0432.CCR-05-2398","volume":"12","author":"A Collado-Hidalgo","year":"2006","unstructured":"Collado-Hidalgo, A., Bower, J. E., Ganz, P. A., Cole, S. W. & Irwin, M. R. Inflammatory biomarkers for persistent fatigue in breast cancer survivors. Clin. Cancer Res. 12(9), 2759\u20132766 (2006).","journal-title":"Clin. Cancer Res."},{"issue":"17","key":"39046_CR5","doi-asserted-by":"publisher","first-page":"5534","DOI":"10.1158\/1078-0432.CCR-08-2584","volume":"15","author":"JE Bower","year":"2009","unstructured":"Bower, J. E. et al. Inflammatory biomarkers and fatigue during radiation therapy for breast and prostate cancerinflammation and fatigue during radiation therapy. Clin. Cancer Res. 15(17), 5534\u20135540 (2009).","journal-title":"Clin. Cancer Res."},{"key":"39046_CR6","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.bbi.2015.10.005","volume":"52","author":"ME Schmidt","year":"2016","unstructured":"Schmidt, M. E. et al. Cancer-related fatigue shows a stable association with diurnal cortisol dysregulation in breast cancer patients. Brain Behav. Immun. 52, 98\u2013105 (2016).","journal-title":"Brain Behav. Immun."},{"issue":"7","key":"39046_CR7","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1097\/PSY.0000000000000097","volume":"76","author":"D Tell","year":"2014","unstructured":"Tell, D., Mathews, H. L. & Janusek, L. W. Day-to-day dynamics of associations between sleep, napping, fatigue and the cortisol diurnal rhythm in women diagnosed with breast cancer. Psychosom. Med. 76(7), 519 (2014).","journal-title":"Psychosom. Med."},{"issue":"11","key":"39046_CR8","doi-asserted-by":"publisher","first-page":"4700","DOI":"10.1158\/0008-5472.CAN-08-4747","volume":"69","author":"PF Innominato","year":"2009","unstructured":"Innominato, P. F. et al. Circadian rhythm in rest and activity: a biological correlate of quality of life and a predictor of survival in patients with metastatic colorectal cancer. Can. Res. 69(11), 4700\u20134707 (2009).","journal-title":"Can. Res."},{"issue":"9","key":"39046_CR9","doi-asserted-by":"publisher","first-page":"4396","DOI":"10.1002\/cam4.1711","volume":"7","author":"PF Innominato","year":"2018","unstructured":"Innominato, P. F. et al. Circadian rest-activity rhythm as an objective biomarker of patient-reported outcomes in patients with advanced cancer. Cancer Med. 7(9), 4396\u20134405 (2018).","journal-title":"Cancer Med."},{"key":"39046_CR10","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.bbi.2020.05.043","volume":"88","author":"AJ Grossberg","year":"2020","unstructured":"Grossberg, A. J. et al. Interleukin 6-independent metabolic reprogramming as a driver of cancer-related fatigue. Brain Behav. Immun. 88, 230\u2013241 (2020).","journal-title":"Brain Behav. Immun."},{"issue":"10","key":"39046_CR11","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/nrclinonc.2014.127","volume":"11","author":"JE Bower","year":"2014","unstructured":"Bower, J. E. Cancer-related fatigue\u2014mechanisms, risk factors, and treatments. Nat. Rev. Clin. Oncol. 11(10), 597\u2013609 (2014).","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"3","key":"39046_CR12","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1158\/0008-5472.CAN-17-2168","volume":"78","author":"AJ Grossberg","year":"2018","unstructured":"Grossberg, A. J. et al. Tumor-associated fatigue in cancer patients develops independently of IL1 signaling. Can. Res. 78(3), 695\u2013705 (2018).","journal-title":"Can. Res."},{"issue":"18","key":"39046_CR13","doi-asserted-by":"publisher","first-page":"1882","DOI":"10.1200\/JCO.2013.54.4346","volume":"32","author":"A Spathis","year":"2014","unstructured":"Spathis, A. et al. Modafinil for the treatment of fatigue in lung cancer: results of a placebo-controlled, double-blind, randomized trial. J. Clin. Oncol. 32(18), 1882\u20131888 (2014).","journal-title":"J. Clin. Oncol."},{"issue":"25","key":"39046_CR14","doi-asserted-by":"publisher","first-page":"3076","DOI":"10.1200\/JCO.2012.44.4661","volume":"31","author":"S Yennurajalingam","year":"2013","unstructured":"Yennurajalingam, S. et al. Reduction of cancer-related fatigue with dexamethasone: a double-blind, randomized, placebo-controlled trial in patients with advanced cancer. J. Clin. Oncol. 31(25), 3076\u20133082 (2013).","journal-title":"J. Clin. Oncol."},{"issue":"6","key":"39046_CR15","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1200\/JCO.2013.49.3437","volume":"32","author":"GH Montgomery","year":"2014","unstructured":"Montgomery, G. H. et al. Randomized controlled trial of a cognitive-behavioral therapy plus hypnosis intervention to control fatigue in patients undergoing radiotherapy for breast cancer. J. Clin. Oncol. 32(6), 557 (2014).","journal-title":"J. Clin. Oncol."},{"issue":"7","key":"39046_CR16","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1001\/jamaoncol.2016.6914","volume":"3","author":"KM Mustian","year":"2017","unstructured":"Mustian, K. M. et al. Comparison of pharmaceutical, psychological, and exercise treatments for cancer-related fatigue: a meta-analysis. JAMA Oncol. 3(7), 961\u2013968 (2017).","journal-title":"JAMA Oncol."},{"issue":"2","key":"39046_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11864-020-0707-5","volume":"21","author":"MS Thong","year":"2020","unstructured":"Thong, M. S., van Noorden, C. J., Steindorf, K. & Arndt, V. Cancer-related fatigue: causes and current treatment options. Curr. Treat. Options Oncol. 21(2), 1\u201319 (2020).","journal-title":"Curr. Treat. Options Oncol."},{"issue":"3","key":"39046_CR18","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.ygyno.2014.10.013","volume":"136","author":"XS Wang","year":"2015","unstructured":"Wang, X. S. & Woodruff, J. F. Cancer-related and treatment-related fatigue. Gynecol. Oncol. 136(3), 446\u2013452 (2015).","journal-title":"Gynecol. Oncol."},{"issue":"10","key":"39046_CR19","doi-asserted-by":"publisher","first-page":"3353","DOI":"10.1007\/s00520-018-4318-7","volume":"26","author":"C O\u2019Higgins","year":"2018","unstructured":"O\u2019Higgins, C., Brady, B., O\u2019Connor, B., Walsh, D. & Reilly, R. The pathophysiology of cancer-related fatigue: current controversies. Support. Care Cancer 26(10), 3353\u20133364 (2018).","journal-title":"Support. Care Cancer"},{"issue":"1","key":"39046_CR20","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.jpainsymman.2020.07.037","volume":"61","author":"M Al Maqbali","year":"2021","unstructured":"Al Maqbali, M., Al Sinani, M., Al Naamani, Z. & Al, B. K. Prevalence of fatigue in patients with cancer: a systematic review and meta-analysis. J. Pain Symptom Manag. 61(1), 167\u2013189 (2021).","journal-title":"J. Pain Symptom Manag."},{"key":"39046_CR21","doi-asserted-by":"publisher","first-page":"103707","DOI":"10.1016\/j.ijnurstu.2020.103707","volume":"111","author":"Y Ma","year":"2020","unstructured":"Ma, Y. et al. Prevalence and risk factors of cancer-related fatigue: A systematic review and meta-analysis. Int. J. Nurs. Stud. 111, 103707 (2020).","journal-title":"Int. J. Nurs. Stud."},{"issue":"1","key":"39046_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2458-13-154","volume":"13","author":"R Herzog","year":"2013","unstructured":"Herzog, R. et al. Are healthcare workers\u2019 intentions to vaccinate related to their knowledge, beliefs and attitudes? A systematic review. BMC Public Health 13(1), 1\u201317 (2013).","journal-title":"BMC Public Health"},{"key":"39046_CR23","unstructured":"Wells, G. A., Shea, B., O\u2019Connell, D., Peterson, J., Welch, V., Losos, M. et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. (Oxford, 2000)."},{"issue":"7","key":"39046_CR24","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1002\/ibd.21530","volume":"17","author":"L-P Jelsness-J\u00f8rgensen","year":"2011","unstructured":"Jelsness-J\u00f8rgensen, L.-P., Bernklev, T., Henriksen, M., Torp, R. & Moum, B. A. Chronic fatigue is more prevalent in patients with inflammatory bowel disease than in healthy controls. Inflamm. Bowel Dis. 17(7), 1564\u20131572 (2011).","journal-title":"Inflamm. Bowel Dis."},{"issue":"1","key":"39046_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-021-00337-z","volume":"11","author":"YM Go\u00ebrtz","year":"2021","unstructured":"Go\u00ebrtz, Y. M. et al. Fatigue in patients with chronic disease: Results from the population-based lifelines cohort study. Sci. Rep. 11(1), 1\u201312 (2021).","journal-title":"Sci. Rep."},{"issue":"58","key":"39046_CR26","doi-asserted-by":"publisher","first-page":"31244","DOI":"10.18632\/oncotarget.25787","volume":"9","author":"TE Lacourt","year":"2018","unstructured":"Lacourt, T. E. et al. Patient\u2013reported fatigue prior to treatment is prognostic of survival in patients with acute myeloid leukemia. Oncotarget 9(58), 31244 (2018).","journal-title":"Oncotarget"},{"issue":"3","key":"39046_CR27","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1038\/ki.2014.86","volume":"86","author":"M Artom","year":"2014","unstructured":"Artom, M., Moss-Morris, R., Caskey, F. & Chilcot, J. Fatigue in advanced kidney disease. Kidney Int. 86(3), 497\u2013505 (2014).","journal-title":"Kidney Int."},{"issue":"4","key":"39046_CR28","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1200\/JCO.2000.18.4.743","volume":"18","author":"JE Bower","year":"2000","unstructured":"Bower, J. E. et al. Fatigue in breast cancer survivors: occurrence, correlates, and impact on quality of life. J. Clin. Oncol. 18(4), 743 (2000).","journal-title":"J. Clin. Oncol."},{"issue":"2","key":"39046_CR29","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/j.jpainsymman.2010.05.017","volume":"41","author":"R Hung","year":"2011","unstructured":"Hung, R. et al. Fatigue and functional impairment in early-stage non-small cell lung cancer survivors. J. Pain Symptom Manag. 41(2), 426\u2013435 (2011).","journal-title":"J. Pain Symptom Manag."},{"issue":"3","key":"39046_CR30","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1002\/cncr.28434","volume":"120","author":"XS Wang","year":"2014","unstructured":"Wang, X. S. et al. Prevalence and characteristics of moderate to severe fatigue: A multicenter study in cancer patients and survivors. Cancer 120(3), 425\u2013432 (2014).","journal-title":"Cancer"},{"issue":"6","key":"39046_CR31","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1093\/annonc\/mdh229","volume":"15","author":"N De Jong","year":"2004","unstructured":"De Jong, N., Candel, M., Schouten, H., Abu-Saad, H. H. & Courtens, A. Prevalence and course of fatigue in breast cancer patients receiving adjuvant chemotherapy. Ann. Oncol. 15(6), 896\u2013905 (2004).","journal-title":"Ann. Oncol."},{"key":"39046_CR32","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.ejca.2018.06.009","volume":"101","author":"H Mao","year":"2018","unstructured":"Mao, H. et al. Prevalence and risk factors for fatigue among breast cancer survivors on aromatase inhibitors. Eur. J. Cancer 101, 47\u201354 (2018).","journal-title":"Eur. J. Cancer"},{"issue":"9","key":"39046_CR33","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1016\/j.parkreldis.2015.07.007","volume":"21","author":"GD Cochrane","year":"2015","unstructured":"Cochrane, G. D. et al. The association between fatigue and apathy in patients with either Parkinson\u2019s disease or multiple sclerosis. Parkinsonism Relat. Disord. 21(9), 1093\u20131095 (2015).","journal-title":"Parkinsonism Relat. Disord."},{"issue":"1","key":"39046_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1477-7525-6-100","volume":"6","author":"O Hadjimichael","year":"2008","unstructured":"Hadjimichael, O., Vollmer, T. & Oleen-Burkey, M. Fatigue characteristics in multiple sclerosis: the North American research committee on multiple sclerosis (NARCOMS) survey. Health Qual. Life Outcomes 6(1), 1\u201311 (2008).","journal-title":"Health Qual. Life Outcomes"},{"issue":"11","key":"39046_CR35","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1212\/WNL.0b013e31821043a4","volume":"76","author":"E Brusse","year":"2011","unstructured":"Brusse, E., Brusse-Keizer, M. G., Duivenvoorden, H. J. & van Swieten, J. C. Fatigue in spinocerebellar ataxia: Patient self-assessment of an early and disabling symptom. Neurology 76(11), 953\u2013959 (2011).","journal-title":"Neurology"},{"issue":"7","key":"39046_CR36","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1200\/JCO.2003.08.163","volume":"21","author":"SD Foss\u00e5","year":"2003","unstructured":"Foss\u00e5, S. D., Dahl, A. A. & Loge, J. H. Fatigue, anxiety, and depression in long-term survivors of testicular cancer. J. Clin. Oncol. 21(7), 1249\u20131254 (2003).","journal-title":"J. Clin. Oncol."},{"issue":"8","key":"39046_CR37","doi-asserted-by":"publisher","first-page":"2809","DOI":"10.1007\/s00520-018-4587-1","volume":"27","author":"AN Tibubos","year":"2019","unstructured":"Tibubos, A. N. et al. Fatigue in survivors of malignant melanoma and its determinants: a register-based cohort study. Support. Care Cancer 27(8), 2809\u20132818 (2019).","journal-title":"Support. Care Cancer"},{"issue":"8","key":"39046_CR38","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1002\/cncr.21364","volume":"104","author":"JT Hickok","year":"2005","unstructured":"Hickok, J. T. et al. Frequency, severity, clinical course, and correlates of fatigue in 372 patients during 5 weeks of radiotherapy for cancer. Cancer 104(8), 1772\u20131778 (2005).","journal-title":"Cancer"},{"issue":"1","key":"39046_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12967-020-02269-0","volume":"18","author":"E-J Lim","year":"2020","unstructured":"Lim, E.-J. et al. Systematic review and meta-analysis of the prevalence of chronic fatigue syndrome\/myalgic encephalomyelitis (CFS\/ME). J. Transl. Med. 18(1), 1\u201315 (2020).","journal-title":"J. Transl. Med."},{"issue":"1","key":"39046_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1037\/0033-2909.134.1.1","volume":"134","author":"M Hagedoorn","year":"2008","unstructured":"Hagedoorn, M., Sanderman, R., Bolks, H. N., Tuinstra, J. & Coyne, J. C. Distress in couples coping with cancer: a meta-analysis and critical review of role and gender effects. Psychol. Bull. 134(1), 1 (2008).","journal-title":"Psychol. Bull."},{"issue":"11","key":"39046_CR41","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1016\/S0959-8049(01)00136-8","volume":"37","author":"M H\u00e4rter","year":"2001","unstructured":"H\u00e4rter, M. et al. Psychiatric disorders and associated factors in cancer: results of an interview study with patients in inpatient, rehabilitation and outpatient treatment. Eur. J. Cancer 37(11), 1385\u20131393 (2001).","journal-title":"Eur. J. Cancer"},{"issue":"12","key":"39046_CR42","doi-asserted-by":"publisher","first-page":"1914","DOI":"10.1093\/annonc\/mdz414","volume":"30","author":"A Wagner","year":"2019","unstructured":"Wagner, A. et al. Gender medicine and oncology: Report and consensus of an ESMO workshop. Ann. Oncol. 30(12), 1914\u20131924 (2019).","journal-title":"Ann. Oncol."},{"issue":"2","key":"39046_CR43","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1007\/s00280-012-2018-4","volume":"71","author":"F M\u00fcller","year":"2013","unstructured":"M\u00fcller, F. et al. Gender-specific elimination of continuous-infusional 5-fluorouracil in patients with gastrointestinal malignancies: Results from a prospective population pharmacokinetic study. Cancer Chemother. Pharmacol. 71(2), 361\u2013370 (2013).","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"11","key":"39046_CR44","doi-asserted-by":"publisher","first-page":"3728","DOI":"10.1158\/1078-0432.CCR-03-0807","volume":"10","author":"S Ostermann","year":"2004","unstructured":"Ostermann, S. et al. Plasma and cerebrospinal fluid population pharmacokinetics of temozolomide in malignant glioma patients. Clin. Cancer Res. 10(11), 3728\u20133736 (2004).","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"39046_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12889-017-4623-y","volume":"17","author":"I Engberg","year":"2017","unstructured":"Engberg, I., Segerstedt, J., Waller, G., Wennberg, P. & Eliasson, M. Fatigue in the general population-associations to age, sex, socioeconomic status, physical activity, sitting time and self-rated health: The northern Sweden MONICA study 2014. BMC Public Health 17(1), 1\u20139 (2017).","journal-title":"BMC Public Health"},{"issue":"4","key":"39046_CR46","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s00520-007-0317-9","volume":"16","author":"KM Davis","year":"2008","unstructured":"Davis, K. M., Lai, J.-S., Hahn, E. A. & Cella, D. Conducting routine fatigue assessments for use in clinical oncology practice: Patient and provider perspectives. Support. Care Cancer 16(4), 379\u2013386 (2008).","journal-title":"Support. Care Cancer"},{"issue":"5","key":"39046_CR47","first-page":"375","volume":"70","author":"AJ Grossberg","year":"2020","unstructured":"Grossberg, A. J. et al. Multidisciplinary standards of care and recent progress in pancreatic ductal adenocarcinoma. CA: Cancer J. Clin. 70(5), 375\u2013403 (2020).","journal-title":"CA: Cancer J. Clin."},{"issue":"17","key":"39046_CR48","doi-asserted-by":"publisher","first-page":"1840","DOI":"10.1200\/JCO.2013.53.4495","volume":"32","author":"JE Bower","year":"2014","unstructured":"Bower, J. E. et al. Screening, assessment, and management of fatigue in adult survivors of cancer: An American society of clinical oncology clinical practice guideline adaptation. J. Clin. Oncol. 32(17), 1840 (2014).","journal-title":"J. Clin. Oncol."},{"issue":"5","key":"39046_CR49","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/S0885-3924(02)00518-3","volume":"24","author":"SD Passik","year":"2002","unstructured":"Passik, S. D. et al. Patient-related barriers to fatigue communication: Initial validation of the fatigue management barriers questionnaire. J. Pain Symptom Manag. 24(5), 481\u2013493 (2002).","journal-title":"J. Pain Symptom Manag."},{"issue":"11","key":"39046_CR50","doi-asserted-by":"publisher","first-page":"3463","DOI":"10.3390\/jcm9113463","volume":"9","author":"D-Y Kim","year":"2020","unstructured":"Kim, D.-Y., Lee, J.-S. & Son, C.-G. Systematic review of primary outcome measurements for chronic fatigue syndrome\/myalgic encephalomyelitis (CFS\/ME) in randomized controlled trials. J. Clin. Med. 9(11), 3463 (2020).","journal-title":"J. Clin. Med."},{"issue":"6","key":"39046_CR51","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1016\/j.jpainsymman.2007.08.012","volume":"35","author":"SH Kim","year":"2008","unstructured":"Kim, S. H. et al. Fatigue and depression in disease-free breast cancer survivors: Prevalence, correlates, and association with quality of life. J. Pain Symptom Manag. 35(6), 644\u2013655 (2008).","journal-title":"J. Pain Symptom Manag."},{"issue":"36","key":"39046_CR52","doi-asserted-by":"publisher","first-page":"4329","DOI":"10.1200\/JCO.2016.67.7450","volume":"34","author":"K Behringer","year":"2016","unstructured":"Behringer, K. et al. Cancer-related fatigue in patients with and survivors of Hodgkin lymphoma: the impact on treatment outcome and social reintegration. J. Clin. Oncol. 34(36), 4329\u20134337 (2016).","journal-title":"J. Clin. Oncol."},{"issue":"11","key":"39046_CR53","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.1007\/s00277-018-3420-8","volume":"97","author":"F Hofer","year":"2018","unstructured":"Hofer, F., Koinig, K., Nagl, L., Borjan, B. & Stauder, R. Fatigue at baseline is associated with geriatric impairments and represents an adverse prognostic factor in older patients with a hematological malignancy. Ann. Hematol. 97(11), 2235\u20132243 (2018).","journal-title":"Ann. Hematol."},{"issue":"11","key":"39046_CR54","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.1093\/annonc\/mdm349","volume":"18","author":"D Storey","year":"2007","unstructured":"Storey, D. et al. Clinically relevant fatigue in cancer outpatients: the Edinburgh cancer centre symptom study. Ann. Oncol. 18(11), 1861\u20131869 (2007).","journal-title":"Ann. Oncol."},{"issue":"5","key":"39046_CR55","doi-asserted-by":"publisher","first-page":"2535","DOI":"10.1002\/cam4.2060","volume":"8","author":"M Matias","year":"2019","unstructured":"Matias, M. et al. Fatigue and physical activity in cancer survivors: A cross-sectional population-based study. Cancer Med. 8(5), 2535\u20132544 (2019).","journal-title":"Cancer Med."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-39046-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-39046-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-39046-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,19]],"date-time":"2023-11-19T04:08:59Z","timestamp":1700366939000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-39046-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,7]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["39046"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-39046-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,7]]},"assertion":[{"value":"23 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"12815"}}